Percutaneous transabdominal approach for the treatment of endoleaks after endovascular repair of infrarenal abdominal aortic aneurysm

Korean J Radiol. 2010 Jan-Feb;11(1):107-14. doi: 10.3348/kjr.2010.11.1.107. Epub 2009 Dec 28.

Abstract

Objective: The purpose of this study was to evaluate the technical feasibility and clinical efficacy of percutaneous transabdominal treatment of endoleaks after endovascular aneurysm repair.

Materials and methods: Between 2000 and 2007, six patients with type I (n = 4) or II (n = 2) endoleaks were treated by the percutaneous transabdominal approach using embolization with N-butyl cyanoacrylate with or without coils. Five patients underwent a single session and one patient had two sessions of embolization. The median time between aneurysm repair and endoleak treatment was 25.5 months (range: 0-84 months). Follow-up CT images were evaluated for changes in the size and shape of the aneurysm sac and presence or resolution of endoleaks. The median follow-up after endoleak treatment was 16.4 months (range: 0-37 months)

Results: Technical success was achieved in all six patients. Clinical success was achieved in four patients with complete resolution of the endoleak confirmed by follow-up CT. Clinical failure was observed in two patients. One eventually underwent surgical conversion, and the other was lost to follow-up. There were no procedure-related complications.

Conclusion: The percutaneous transabdominal approach for the treatment of type I or II endoleaks, after endovascular aneurysm repair, is an alternative method when conventional endovascular methods have failed.

Keywords: Abdominal aortic aneurysm; Embolization; Endoleak; Endovascular aneurysm repair; N-butyl cyanoacrylate.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Aortic Aneurysm, Abdominal / surgery*
  • Blood Vessel Prosthesis Implantation*
  • Embolization, Therapeutic / methods*
  • Enbucrilate / administration & dosage*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Postoperative Complications / therapy*
  • Punctures
  • Stents*

Substances

  • Enbucrilate